Erythropoietin resistance among pediatric patients on chronic hemodialysis: A cross-sectional study
- PMID: 40293460
- DOI: 10.1007/s00467-025-06776-4
Erythropoietin resistance among pediatric patients on chronic hemodialysis: A cross-sectional study
Abstract
Background: The erythropoietin resistance index (ERI) is an accurate indicator of erythropoietin (EPO) resistance and is related to a worse prognosis in patients on hemodialysis (HD). ERI is simple, cheap and could be calculated easily in children receiving HD. We aimed to assess the EPO resistance in children with kidney failure on regular HD.
Methods: An analytical cross-sectional study was conducted on 80 children with kidney failure on regular HD. They were assessed by history taking and laboratory investigations including complete blood count, C- reactive protein (CRP), iron, ferritin, parathyroid hormone and serum electrolytes. ERI was calculated.
Results: The study included 80 patients; 41 (51.2%) were male. The mean age of the study group was 8.86 ± 2.76 years. Sixty-three patients (78.8%) were on iron therapy. Mean ERI was 28.87 ± 10.62. The ERI was significantly positively correlated with age (r = 0.242; P = 0.031), EPO dose (r = 0.290; P = 0.001) and CRP (r = 0.219; P = 0.049). The ERI had a significantly negative correlation with KT/V (r = - 0.262; P = 0.019), hemoglobin level (r = - 0.265; P = 0.001) and platelet count (r = - 0.254; P = 0.023).
Conclusions: Erythropoietin resistance is associated with many risk factors, including high CRP and low KT/V. Inadequate HD is the most important risk factor for EPO resistance in children on chronic HD. Adequate HD is considered as a protective measure against EPO resistance.
Keywords: Erythropoietin resistance; Erythropoietin resistance index; Hemodialysis; Kidney failure; Pediatrics.
© 2025. The Author(s).
Conflict of interest statement
Declarations. Ethics approval and consent to participate: The study has been approved by the Research Ethics Committee, Faculty of Medicine, Cairo University (approval code: MS- 95–2022). Written informed consent was obtained from the parents or legal guardians of the children. Consent for publication: Not applicable. Competing interests: The authors declare that they have no competing interests.
Similar articles
-
Acute-phase response predicts erythropoietin resistance in hemodialysis and peritoneal dialysis patients.Am J Kidney Dis. 1999 Jan;33(1):63-72. doi: 10.1016/s0272-6386(99)70259-3. Am J Kidney Dis. 1999. PMID: 9915269
-
Hemodialysis treatment time versus erythropoietin dose requirement: Reduction in 2,000 units per week by extension of hemodialysis for 1 hour .Clin Nephrol. 2019 Oct;92(4):174-179. doi: 10.5414/CN109403. Clin Nephrol. 2019. PMID: 31272526
-
Iron Indices Mediate but Not Modify Association of Parathyroid Hormone with Erythropoietin Resistance in Hemodialysis Patients.Blood Purif. 2024;53(7):583-590. doi: 10.1159/000539080. Epub 2024 May 6. Blood Purif. 2024. PMID: 38710167
-
Recombinant human erythropoietin independence in chronic hemodialysis patients: clinical features, iron homeostasis and erythropoiesis.Clin Nephrol. 2005 Feb;63(2):92-7. doi: 10.5414/cnp63092. Clin Nephrol. 2005. PMID: 15730050
-
Neutrophil-to-Lymphocyte Ratio and Erythropoietin Resistance among Maintenance Hemodialysis Patients.Blood Purif. 2022;51(8):708-713. doi: 10.1159/000519644. Epub 2021 Oct 14. Blood Purif. 2022. PMID: 34649238
Cited by
-
Comment on: Erythropoietin resistance among pediatric patients on chronic hemodialysis: A cross-sectional study.Pediatr Nephrol. 2025 May 26. doi: 10.1007/s00467-025-06835-w. Online ahead of print. Pediatr Nephrol. 2025. PMID: 40418278 No abstract available.
References
-
- Portoles J, Martin L, Broseta JJ, Cases A (2021) Anemia in chronic kidney disease: from pathophysiology and current treatments to future agents. Front Med 8:642296 - DOI
-
- Birnie K, Caskey F, Ben-Shlomo Y, Sterne JA, Gilg J, Nitsch D et al (2017) Erythropoiesis-stimulating agent dosing, haemoglobin and ferritin levels in UK haemodialysis patients 2005–13. Nephrol Dial Transplant 32:692–698 - PubMed
-
- Putri RGP, Sholihah A, Sukirto NW (2020) Risk factor for erythropoietin resistance in hemodialysis patient: literature review. Ahmad Dahlan Med J 1:33–49 - DOI
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous